North China Pharmaceutical Company Ltd.SSE: 600812

Announcement on Implementation of Dividend Distribution for 2025

Jun 5, 2026 · Issued by North China Pharmaceutical Company Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 5, 2026 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2025-167

Release

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

North China Pharmaceutical Company Ltd. on 6ix

Earlier from North China Pharmaceutical

Announcement on Election of Employee DirectorMay 21
Announcement on Convening Performance Briefing for 2025 and Q1 2026May 8
Announcement on Release of Pledge and Pledge of Some Shares of ShareholdersApr 29
Notice on Convening the 2025 Annual General MeetingApr 25
Announcement on Renewing Engagement of Accounting FirmApr 18

Later from North China Pharmaceutical

Announcement on Obtaining Drug Registration CertificateJun 24
Announcement on Inclusion of Products of the Company and Its Subsidiaries in the National Essential Medicines ListJul 11
Announcement on the Proposed Selection of Drugs of the Company and Its Subsidiaries in the National Centralized Drug ProcurementAug 4
Announcement on Resignation of Senior ManagementAug 6
Semi-annual Report for 2026Aug 22

All North China Pharmaceutical news releases

Follow North China Pharmaceutical into a list and get an email when it puts out news.

Follow North China Pharmaceutical